Tonix Pharmaceuticals Holding Corp. ( TNXP) - Stock Earnings
TNXP Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 9, 2026, midnight | — / — | — | — / — | — |
TNXP Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -46.9 million USD | 5.4 million USD |
| 2026Q1 | -40.2 million USD | 6.9 million USD |
| 2026Q2 | -40.6 million USD | 13.5 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
TNXP Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -116.7 million USD | 7.8 million USD |
| 2024 | -130.0 million USD | 10.1 million USD |
| 2025 | -124.0 million USD | 13.1 million USD |
| 2026 Est. | — | — |
TNXP
Price: $6.04
Earnings Per Share: -13.09 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 943700
Ebitda: -5.8 millionMarket Capitalization: 122.7 million